[go: up one dir, main page]

ITMI20042232A1 - PHARMACEUTICAL COMPOSITION CONTAINING CLOZAPINE - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING CLOZAPINE

Info

Publication number
ITMI20042232A1
ITMI20042232A1 IT002232A ITMI20042232A ITMI20042232A1 IT MI20042232 A1 ITMI20042232 A1 IT MI20042232A1 IT 002232 A IT002232 A IT 002232A IT MI20042232 A ITMI20042232 A IT MI20042232A IT MI20042232 A1 ITMI20042232 A1 IT MI20042232A1
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
composition containing
containing clozapine
clozapine
pharmaceutical
Prior art date
Application number
IT002232A
Other languages
Italian (it)
Inventor
Enrico Malizia
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Priority to IT002232A priority Critical patent/ITMI20042232A1/en
Publication of ITMI20042232A1 publication Critical patent/ITMI20042232A1/en
Priority to PCT/IB2005/003437 priority patent/WO2006059194A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
IT002232A 2004-11-19 2004-11-19 PHARMACEUTICAL COMPOSITION CONTAINING CLOZAPINE ITMI20042232A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT002232A ITMI20042232A1 (en) 2004-11-19 2004-11-19 PHARMACEUTICAL COMPOSITION CONTAINING CLOZAPINE
PCT/IB2005/003437 WO2006059194A2 (en) 2004-11-19 2005-11-16 Pharmaceutical sustained-release composition containing clozapine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002232A ITMI20042232A1 (en) 2004-11-19 2004-11-19 PHARMACEUTICAL COMPOSITION CONTAINING CLOZAPINE

Publications (1)

Publication Number Publication Date
ITMI20042232A1 true ITMI20042232A1 (en) 2005-02-19

Family

ID=36565404

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002232A ITMI20042232A1 (en) 2004-11-19 2004-11-19 PHARMACEUTICAL COMPOSITION CONTAINING CLOZAPINE

Country Status (2)

Country Link
IT (1) ITMI20042232A1 (en)
WO (1) WO2006059194A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2414903C1 (en) * 2009-10-23 2011-03-27 Маргарита Алексеевна Морозова Pharmaceutical composition of prolonged action based on clozapine of peroral introduction
MX395554B (en) 2016-09-17 2025-03-25 Intas Pharmaceuticals Ltd PHARMACEUTICAL COMPOSITION OF EXTENDED-RELEASE CLOZAPINE.
MX2020008060A (en) 2018-01-31 2020-12-07 Zarodex Therapeutics Ltd Clozapine for the treatment of a immunoglobulin driven b cell disease.
JP2021513523A (en) 2018-01-31 2021-05-27 ザロデックス セラピューティクス リミテッド Clozapine for the treatment of IgE-driven B-cell disease
EP3520803A1 (en) 2018-01-31 2019-08-07 Zarodex Therapeutics Limited Novel uses
GB201910873D0 (en) 2019-07-30 2019-09-11 Zarodex Therapeutics Ltd Novel uses
US11648207B1 (en) * 2021-12-15 2023-05-16 Intas Pharmaceuticals Ltd. Extended release pharmaceutical composition of Clozapine
US11918590B2 (en) 2021-12-15 2024-03-05 Intas Pharmaceuticals Ltd. Stable extended release pharmaceutical composition of clozapine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2148823C (en) * 1992-11-17 1999-03-09 Welfide Corporation Sustained release microsphere preparation containing antipsychotic drug and production process thereof
US6197764B1 (en) * 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof

Also Published As

Publication number Publication date
WO2006059194A3 (en) 2006-08-31
WO2006059194A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
HUS1400051I1 (en) Pharmaceutical composition containing lurazidone
BRPI0511900A (en) pharmaceutical compositions
ITBO20050123A1 (en) GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
EP1788047A4 (en) HYDROFUGE / OLEOFUGE COMPOSITION
BRPI0715712A2 (en) PHARMACEUTICAL COMPOSITION
BRPI0613033A2 (en) oral composition
BRPI0719393A2 (en) Pharmaceutical Composition
DK1940467T3 (en) Long-release drug composition
FR2862654B1 (en) FILMOGENATED AMYLACEE COMPOSITION
DK1725218T3 (en) Pharmaceutical composition comprising pimobendan
DK1587478T3 (en) PHARMACEUTICAL COMPOSITION
BRPI0716445A2 (en) pharmaceutical composition
BRPI0720234A2 (en) PHARMACEUTICAL COMPOSITION
DK1957073T3 (en) PHARMACEUTICAL
ES2845143T8 (en) Stable thrombin composition
DK2033629T3 (en) Solid pharmaceutical composition comprising valsartan
DK1757293T3 (en) BH4-RESPONSIVE HYPERPHENYLALANINARY MEDICINES
SE0302495L (en) Transport composition
DK1985303T3 (en) Oral composition containing interferon-alpha
DE602005017191D1 (en) ODOR-REDUCED WASHPIECE COMPOSITION
ITMI20042232A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING CLOZAPINE
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
FR2871686B1 (en) ANTI-DECOLORATION COMPOSITION
EP1862184A4 (en) PHARMACEUTICAL COMPOSITION
ITMI20041447A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING GABAPENTINA